Bill Sutherland

Stock Analyst at Benchmark Co.

(3.55)
# 2,240
Out of 4,604 analysts
242
Total ratings
43.5%
Success rate
4%
Average return

Stocks Rated by Bill Sutherland

agilon health
Aug 6, 2026
Maintained: Buy
Price Target: $95$140
Current: $92.42
Upside: +51.48%
Omnicell
Jul 30, 2026
Maintained: Buy
Price Target: $60
Current: $36.48
Upside: +64.47%
Prenetics Global
Jul 15, 2026
Maintained: Buy
Price Target: $30$40
Current: $17.98
Upside: +122.53%
CoreCivic
Jul 7, 2026
Maintained: Buy
Price Target: $36$41
Current: $32.71
Upside: +25.34%
Huron Consulting Group
Jun 16, 2026
Maintained: Buy
Price Target: $215
Current: $148.85
Upside: +44.44%
HeartBeam
May 15, 2026
Maintained: Buy
Price Target: $8$5
Current: $0.5092
Upside: +881.93%
Healthcare Services Group
Apr 23, 2026
Maintained: Buy
Price Target: $28$30
Current: $22.29
Upside: +34.59%
RCM Technologies
Apr 8, 2026
Maintained: Buy
Price Target: $32$36
Current: $28.99
Upside: +24.18%
Nutex Health
Mar 10, 2026
Rated: Buy
Price Target: $300
Current: $155.19
Upside: +93.31%
Surgery Partners
Mar 4, 2026
Maintained: Buy
Price Target: $30$24
Current: $15.08
Upside: +59.15%
Maintained: Hold
Price Target: n/a
Current: $31.69
Upside: -
Maintained: Buy
Price Target: $4.5
Current: $2.35
Upside: n/a
Maintained: Buy
Price Target: $7
Current: $0.0003
Upside: n/a
Maintained: Buy
Price Target: $8$4
Current: $0.0005
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $12.29
Upside: n/a
Upgraded: Buy
Price Target: $5
Current: $2.94
Upside: n/a
Reiterated: Buy
Price Target: $9$7
Current: $0.5879
Upside: n/a
Upgraded: Buy
Price Target: $2
Current: $0.000001
Upside: n/a